Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
0.8132
-0.0267 (-3.18%)
At close: Nov 6, 2026, 4:00 PM EST
0.8500
+0.0368 (4.53%)
After-hours: Nov 6, 2026, 7:30 PM EST
Organogenesis Holdings Employees
Organogenesis Holdings had 854 employees as of December 31, 2025. The number of employees decreased by 15 or 1.73% compared to the previous year. That makes Organogenesis Holdings the 16,010th largest employer in the world and 2,290th in the United States.
Employees
854
Change (1Y)
-15
Growth (1Y)
-1.73%
Revenue / Employee
$412,233
Profits / Employee
-$179,327
Market Cap
105.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 854 | -15 | -1.73% |
| Dec 31, 2024 | 869 | 7 | 0.81% |
| Dec 31, 2023 | 862 | -168 | -16.31% |
| Dec 31, 2022 | 1,030 | 80 | 8.42% |
| Dec 31, 2021 | 950 | 40 | 4.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,120 |
| Glass House Brands | 426 |
| Zhengye Biotechnology Holding | 269 |
| Anika Therapeutics | 235 |
| Akebia Therapeutics | 194 |
| ADC Therapeutics | 193 |
| Cumberland Pharmaceuticals | 88 |
| Journey Medical | 58 |
ORGO News
- 3 days ago - Organogenesis Holdings Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Organogenesis Holdings Earnings release: Q3 2026 - Filings
- 3 days ago - Organogenesis Holdings Quarterly report: Q3 2026 - Filings
- 3 days ago - Organogenesis Holdings Inc. Reports Third Quarter 2026 Financial Results - GlobeNewsWire
- 27 days ago - Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers - GlobeNewsWire
- 27 days ago - Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026 - GlobeNewsWire
- 6 weeks ago - These beaten-down stocks could bounce back in January, if history is any guide - Market Watch
- 3 months ago - Organogenesis price target lowered to $2 from $3 at Truist - TheFly